Stock NBSE NEUBASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. NeuBase Therapeutics, Inc.

Equities

NBSE

US64132K2015

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.4396 USD -0.54% Intraday chart for NeuBase Therapeutics, Inc. +2.23% -40.60%
Mar. 26 Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading MT
Mar. 26 US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment
DJ
Oppenheimer Downgrades NeuBase Therapeutics to Perform From Outperform, Removes $15 Price Target
MT
NeuBase Therapeutics Downgraded by RBC to Sector From Outperform, Price Target Slashed to $1 From $12 Amid Restructuring; Speculative Risk Kept
MT
Chardan Capital Downgrades NeuBase Therapeutics to Neutral from Buy
MT
Oppenheimer Adjusts NeuBase Therapeutics Price Target to $15 From $17, Maintains Outperform Rating
MT
Chardan Research Cuts Price Target on NeuBase Therapeutics to $7 From $9, Reiterates Buy Rating
MT
HC Wainwright Adjusts NeuBase Therapeutics' Price Target to $10 From $15, Keeps Buy Rating
MT
Chardan Capital Adjusts NeuBase Therapeutics' Price Target to $9 from $18, Keeps Buy Rating
MT
NEUBASE THERAPEUTICS : RBC Trims Price Target on NeuBase Therapeutics to $15 From $16 to Reflect Operating Expenses; Outperform, Speculative Risk Kept
MT
NEUBASE THERAPEUTICS : HC Wainwright Adjusts Price Target on NeuBase Therapeutics to $15 From $18, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NBSE Stock
  4. News NeuBase Therapeutics, Inc.
  5. Analyst Reco.